106 related articles for article (PubMed ID: 7927883)
21. Characterisation of a vindesine-resistant human small-cell lung cancer cell line.
Ohta S; Nishio K; Kubo S; Nishio M; Ohmori T; Takahashi T; Saijo N
Br J Cancer; 1993 Jul; 68(1):74-9. PubMed ID: 8391305
[TBL] [Abstract][Full Text] [Related]
22. Fractionated irradiation of H69 small-cell lung cancer cells causes stable radiation and drug resistance with increased MRP1, MRP2, and topoisomerase IIalpha expression.
Henness S; Davey MW; Harvie RM; Davey RA
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):895-902. PubMed ID: 12377343
[TBL] [Abstract][Full Text] [Related]
23. Tyrosine phosphorylation of p34cdc2 is regulated by protein phosphatase 2A in growing immature Xenopus oocytes.
Rime H; Jessus C; Ozon R
Exp Cell Res; 1995 Jul; 219(1):29-38. PubMed ID: 7543054
[TBL] [Abstract][Full Text] [Related]
24. Multidrug-resistant human KB carcinoma cells are highly resistant to the protein phosphatase inhibitors okadaic acid and calyculin A. Analysis of potential mechanisms involved in toxin resistance.
Chambers TC; Raynor RL; Kuo JF
Int J Cancer; 1993 Jan; 53(2):323-7. PubMed ID: 8093882
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of okadaic acid derivatives on protein phosphatases. A study on structure-affinity relationship.
Takai A; Murata M; Torigoe K; Isobe M; Mieskes G; Yasumoto T
Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):539-44. PubMed ID: 1318034
[TBL] [Abstract][Full Text] [Related]
26. Okadaic acid, a potent inhibitor of type 1 and type 2A protein phosphatases, activates cdc2/H1 kinase and transiently induces a premature mitosis-like state in BHK21 cells.
Yamashita K; Yasuda H; Pines J; Yasumoto K; Nishitani H; Ohtsubo M; Hunter T; Sugimura T; Nishimoto T
EMBO J; 1990 Dec; 9(13):4331-8. PubMed ID: 2176149
[TBL] [Abstract][Full Text] [Related]
27. Modulation of cytolytic T lymphocyte functions by an inhibitor of serine/threonine phosphatase, okadaic acid. Enhancement of cytolytic T lymphocyte-mediated cytotoxicity.
Taffs RE; Redegeld FA; Sitkovsky MV
J Immunol; 1991 Jul; 147(2):722-8. PubMed ID: 1649222
[TBL] [Abstract][Full Text] [Related]
28. Protein serine/threonine phosphatases as binding proteins for okadaic acid.
Nagao M; Shima H; Nakayasu M; Sugimura T
Mutat Res; 1995 Dec; 333(1-2):173-9. PubMed ID: 8538625
[TBL] [Abstract][Full Text] [Related]
29. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
30. Induction of differentiation and c-jun expression in human leukemic cells by okadaic acid, an inhibitor of protein phosphatases.
Adunyah SE; Unlap TM; Franklin CC; Kraft AS
J Cell Physiol; 1992 May; 151(2):415-26. PubMed ID: 1315324
[TBL] [Abstract][Full Text] [Related]
31. Involvement of proteolytic activation of PKCdelta in cisplatin-induced apoptosis in human small cell lung cancer H69 cells.
Persaud SD; Hoang V; Huang J; Basu A
Int J Oncol; 2005 Jul; 27(1):149-54. PubMed ID: 15942654
[TBL] [Abstract][Full Text] [Related]
32. An anti-okadaic acid-anti-idiotypic antibody bearing an internal image of okadaic acid inhibits protein phosphatase PP1 and PP2A catalytic activity.
Shestowky WS; Holmes CF; Hu T; Marr J; Wright JL; Chin J; Sikorska HM
Biochem Biophys Res Commun; 1993 Apr; 192(1):302-10. PubMed ID: 8386509
[TBL] [Abstract][Full Text] [Related]
33. Activation of the mouse IL-2 gene by okadaic acid: synergy with interleukin-1.
Falk W; Stricker K; Praast G; Tsukitani Y; Krammer PH; Stoeck M
Lymphokine Cytokine Res; 1994 Jun; 13(3):167-74. PubMed ID: 7948425
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of okadaic acid on bone resorption in neonatal mouse calvaria in vitro. Protein dephosphorylation as an important regulatory mechanism in the bone resorption process.
Feyen JH; Kuntzelmann GM
Biochem Biophys Res Commun; 1991 Jul; 178(2):758-63. PubMed ID: 1650197
[TBL] [Abstract][Full Text] [Related]
35. Dual effect of phosphatase inhibitors on calcium channels in intestinal smooth muscle cells.
Obara K; Yabu H
Am J Physiol; 1993 Feb; 264(2 Pt 1):C296-301. PubMed ID: 8383427
[TBL] [Abstract][Full Text] [Related]
36. Thyrsiferyl 23-acetate is a novel specific inhibitor of protein phosphatase PP2A.
Matsuzawa S; Suzuki T; Suzuki M; Matsuda A; Kawamura T; Mizuno Y; Kikuchi K
FEBS Lett; 1994 Dec; 356(2-3):272-4. PubMed ID: 7805852
[TBL] [Abstract][Full Text] [Related]
37. Okadaic acid. Protein phosphatase inhibition and muscle contractile effects.
Takai A
J Muscle Res Cell Motil; 1988 Dec; 9(6):563-5. PubMed ID: 2850299
[TBL] [Abstract][Full Text] [Related]
38. Contrasting effects of two tumour promoters, phorbol myristate acetate and okadaic acid, on T-cell responses and activation of p42 MAP-kinase/ERK-2.
Amaral MC; Casillas AM; Nel AE
Immunology; 1993 May; 79(1):24-31. PubMed ID: 8389730
[TBL] [Abstract][Full Text] [Related]
39. Regulation of p42 mitogen-activated-protein kinase activity by protein phosphatase 2A under conditions of growth inhibition by epidermal growth factor in A431 cells.
Chajry N; Martin PM; Cochet C; Berthois Y
Eur J Biochem; 1996 Jan; 235(1-2):97-102. PubMed ID: 8631373
[TBL] [Abstract][Full Text] [Related]
40. Okadaic acid markedly potentiates the heat-induced hsp 70 promoter activity.
Chang NT; Huang LE; Liu AY
J Biol Chem; 1993 Jan; 268(2):1436-9. PubMed ID: 8380412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
